Feldman Alexander, Voskoboinik Aleksandr, Kumar Saurabh, Spence Steven, Morton Joseph B, Kistler Peter M, Sparks Paul B, Vohra Jitendra K, Kalman Jonathan M
Department of Cardiology, Royal Melbourne Hospital, Department of Medicine, University of Melbourne, Melbourne, Australia.
Pacing Clin Electrophysiol. 2011 Aug;34(8):927-33. doi: 10.1111/j.1540-8159.2011.03092.x. Epub 2011 May 13.
Atrioventricular nodal reentrant tachycardia (AVNRT) is the most common mechanism of supraventricular tachycardia. Slow pathway (SP) ablation is the first-line treatment approach with a high acute success rate and a low risk of inadvertent complete atrioventricular (AV) block. However, there is still some uncertainty as to the most appropriate procedural endpoints and the impact of these on risk of recurrence. We report the acute and long-term results of SP ablation in a large single-center consecutive series and analyze predictors of acute success and late recurrence.
The study included 1,448 consecutive procedures in 1,419 patients with AVNRT (mean age 49 ± 17 years, 66% women) who underwent SP ablation using a combined electrophysiologic and anatomic approach. Univariate and multivariate analysis was performed for potential predictors of acute success and late recurrence.
Acute success was achieved in 98.1%. Transient (first, second, or third degree) AV block occurred during the procedure in 20 (1.41%) patients. One patient (0.07%) had persistent first-degree and transient second-degree AV block after ablation and underwent pacemaker implant at day 21. Of the 1,391 patients with successful ablation, 22 patients (1.5%) developed AVNRT recurrence during a follow-up period of 63 ± 38 months. The only independent predictor of reduced procedural success was the presence of atypical AVNRT (hazard ratio 3.1, P = 0.04). Independent predictors of AVNRT recurrence were age <20 years and female gender (hazard ratios 14.1 and 3.7, respectively). No significant difference in the incidence of late recurrence was observed in patients with or without residual slow-pathway conduction, or according to use of isoproterenol testing or general anesthesia. However, patients with a single echo with recurrence had a significantly larger echo window (median 85 ms) than those without (median 30 ms, P = 0.01).
This study demonstrates in a large consecutive single-center series that SP ablation using radiofrequency energy is a highly effective procedure with an extremely low risk of inadvertent AV block and a low recurrence rate. We found that single-AV nodal echo beats represented a procedural endpoint that did not predict AVNRT recurrence but that a large echo window is associated with recurrence. Recurrence rates in this series were higher in young women, possibly reflecting a more conservative approach to ablation in this age group.
房室结折返性心动过速(AVNRT)是室上性心动过速最常见的机制。慢径路(SP)消融是一线治疗方法,急性成功率高,发生意外完全性房室(AV)传导阻滞的风险低。然而,对于最合适的手术终点及其对复发风险的影响仍存在一些不确定性。我们报告了一个大型单中心连续系列中SP消融的急性和长期结果,并分析了急性成功和晚期复发的预测因素。
该研究纳入了1419例AVNRT患者(平均年龄49±17岁,66%为女性)的1448例连续手术,这些患者采用电生理和解剖相结合的方法进行SP消融。对急性成功和晚期复发的潜在预测因素进行单因素和多因素分析。
急性成功率为98.1%。20例(1.41%)患者在手术过程中出现短暂性(一度、二度或三度)AV传导阻滞。一名患者(0.07%)在消融后出现持续性一度和短暂性二度AV传导阻滞,并在第21天接受了起搏器植入。在1391例消融成功的患者中,22例(1.5%)在63±38个月的随访期内发生AVNRT复发。手术成功率降低的唯一独立预测因素是非典型AVNRT的存在(风险比3.1,P = 0.04)。AVNRT复发的独立预测因素是年龄<20岁和女性(风险比分别为14.1和3.7)。有无残余慢径路传导的患者,或根据是否使用异丙肾上腺素试验或全身麻醉,晚期复发发生率无显著差异。然而,有单次复发回声的患者的回声窗(中位数85毫秒)明显大于无复发回声的患者(中位数30毫秒,P = 0.01)。
本研究在一个大型连续单中心系列中表明,使用射频能量进行SP消融是一种高效的手术,意外AV传导阻滞的风险极低,复发率低。我们发现单房室结回声搏动代表一个手术终点,它不能预测AVNRT复发,但大的回声窗与复发相关。该系列中年轻女性的复发率较高,这可能反映了该年龄组在消融方面采取了更为保守的方法。